ctDNA’s evolving role in cancer treatment
Yüksel Ürün shared on X:
“The NCI Workshop highlighted ctDNA’s evolving role in cancer treatment. From predicting drug responses to monitoring minimal residual disease, ctDNA offers promising avenues for precision oncology.”
NCI Workshop on ctDNA in Cancer Treatment and Clinical Care
Authors: Brian S Sorg, Jung S Byun, V Anne Westbrook, James V Tricoli, James H Doroshow, Lyndsay N Harris.
Source: Yüksel Ürün/X
Other posts featuring Yüksel Ürün on OncoDaily.
Yüksel Ürün is a Medical Oncology professor at Ankara University School of Medicine in Turkey. His research focuses on genitourinary cancers, covering epidemiology, diagnosis, biomarkers, meta-analysis, and treatment outcomes. His dedication to patient care and research inspires positive change in the medical field.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023